Donovan Joanne M.

CIK 00016440872 companiesBOULDER, CO

SEC Profile

Transactions

Companies

Filings

CIK

0001644087

Recent Transactions

43 trades

Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-04-01$7.08/sh+28,662→ 38,259 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2026-04-01−28,662→ 125,000 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-04-01$32.31/sh−28,662→ 9,597 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-03-31$7.08/sh+21,338→ 30,935 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2026-03-31−21,338→ 153,662 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-03-31$32.12/sh−21,338→ 9,597 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-03-27$30.98/sh−6,735→ 9,597 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2026-03-27$30.98/sh−9,623→ 16,332 total
Award
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2025-08-12+28,125→ 28,125 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-08-12$13.39/sh−2,862→ 25,361 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-08-12+5,781→ 28,223 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-08-12+168,750→ 168,750 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2025-08-12−5,781→ 17,344 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-05-02$16.45/sh−5,187→ 21,588 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-05-01+10,417→ 26,775 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2025-05-01−10,417→ 0 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-01-28$27.63/sh−25,000→ 16,358 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2025-01-28−25,000→ 175,000 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2025-01-28$7.08/sh+25,000→ 41,358 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-09-20$28.29/sh−7,162→ 14,538 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2024-08-12+138,750→ 138,750 total
Award
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2024-08-12+23,125→ 23,125 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-05-02$18.91/sh−3,682→ 19,897 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2024-05-01−10,417→ 10,417 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2024-05-01+10,417→ 23,579 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2023-08-17+200,000→ 200,000 total
Sale
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2023-05-02$8.90/sh−3,254→ 9,960 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2023-05-01−10,416→ 20,834 total
Exercise/Conversion
Edgewise Therapeutics, Inc.$EWTX
Common Stock
2023-05-01+10,416→ 13,214 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2022-08-08+240,000→ 240,000 total
Award
Edgewise Therapeutics, Inc.$EWTX
Restricted Stock Units
2022-05-01+31,250→ 31,250 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2021-08-17+160,000→ 160,000 total
Award
Edgewise Therapeutics, Inc.$EWTX
Stock Option (Right to Buy)
2021-04-30+160,000→ 160,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2020-02-12+60,000→ 60,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2019-02-13+40,000→ 40,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2018-09-07+150,000→ 150,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2018-02-08+100,000→ 100,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2017-02-09+100,000→ 100,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2016-09-08+45,000→ 45,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2016-09-08+45,000→ 45,000 total
Award
Astria Therapeutics, Inc.$ATXS
Stock Option (right to buy)
2016-02-11+66,000→ 66,000 total
Conversion
Astria Therapeutics, Inc.$ATXS
Common Stock
2015-06-30+409→ 409 total
Conversion
Astria Therapeutics, Inc.$ATXS
Series B Preferred Stock
2015-06-30−5,261→ 0 total

Companies

Recent Filings

Address

C/O EDGEWISE THERAPEUTICS, INC. 1715 38TH STREET

BOULDER, CO, 80301

View on SEC.gov